Pacira Biosciences
PCRX
#6188
Rank
S$1.15 B
Marketcap
S$26.89
Share price
2.82%
Change (1 day)
-23.68%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: S$1.15 Billion

As of February 2026 Pacira Biosciences has a market cap of S$1.15 Billion. This makes Pacira Biosciences the world's 6188th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.15 B-24.36%
2025S$1.52 B24.01%
2024S$1.23 B-40.4%
2023S$2.06 B-12.87%
2022S$2.37 B-34.46%
2021S$3.62 B5.36%
2020S$3.43 B34.37%
2019S$2.55 B5.64%
2018S$2.42 B-2.19%
2017S$2.47 B41.67%
2016S$1.74 B-56.32%
2015S$4.00 B-5.49%
2014S$4.23 B72.86%
2013S$2.45 B251.53%
2012S$0.69 B261.12%
2011S$0.19 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Pacira Biosciences was reported to be:

S$1.12 Billion
by Nasdaq info icon info icon
S$1.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
S$1.90 B 65.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
S$0.15 B-86.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
S$1.05 B-8.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
S$0.58 B-49.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
S$0.32 B-72.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
S$10.32 M-99.11%๐Ÿ‡บ๐Ÿ‡ธ USA